AMR Vocabulary

Oral

Public-private-partnership (in Danish: O-P-P)

Point prevalence survey

Probability of target attainment

Performance of Veterinary Services

Quality-adjusted life years: A measure used in health economics to assess the value of a medical intervention. It combines the length of life gained from a treatment with the quality of that life. A QALY is equal to one year of life in perfect health. The measure is often used to calculate a cost-per-QALY value, which helps policymakers and healthcare providers make decisions about the cost-effectiveness of different treatments. The monetary value of a QALY can vary widely depending on the country, time period, and the specific methodology used for its calculation.

Qualified Infectious Disease Product

Quinolone resistance-determining region

Research and development

Recurrent Clostridium difficile infection

Randomized Clinical Trial

Action on Antibiotic Resistance (Uppsala University, Sweden)

Rifampicin-resistant tuberculosis

Research & Technology Organization

Prescription

Sector Association Representatives

Software as a Service (previously known as ASP, application service provider)

Specialist Advisory Committee on Antimicrobial Resistance (UK, Dept. of Health)

Single ascending dose

Serious adverse event

Surgical antibiotic prophylaxis

Serine β-lactamase

Sustainability and Development Goals

Selective index

Systemic inflammatory response syndrome

Small and medium-sized enterprise (<250 according to EU definition)

Systematized Nomenclature of Medicine-Clinical Terms vs. DSM-IV and ICD-10. These are other standards for common language in medicine. The former, DSM-IV is American and stands for: Diagnostic and Statistic Manual version 4 and the latter is WHO’s system: International Classification of Diseases, version 10.

Standard of care

Structured Operational Research and Training IniTiative

Societal Readiness Level

Surgical site infection

Sequence type

Strategies to Address Antimicrobial Resistance, US act introduced November 2007

Strategic Alliance for Research on Infectious Diseases of Animals and Zoonoses

Tuberculosis

Treatment emergent adverse events

Tandvårds- och läkemedelsförmånsverket (Dental and Pharmaceutical Benefits Agency)

Test-of-cure

(Impact Investment Initiative for Global Health): An initiative endorsed at the 2023 G7 Hiroshima Summit focused on connecting stakeholders and mobilizing private capital through impact investment. It aims to address critical global health issues—including the financial and developmental burdens of antimicrobial resistance (AMR)—by driving sustainable private and public financing, particularly in low- and middle-income countries (LMICs).

Technology Readiness Level, term and system developed to guide on a product or service’s go-to-market maturity

Technology Readiness Level - Implementation Science framework

Toxic Shock Syndrome

Technology Transfer Office, entity at university dedicated to bringing academic inventions to use by industry and society

Time to positivity

Unique Device Identifier

(Usual Drug Resistance): Any resistance profile that is not MDR, XDR, or PDR. This is the current expected pattern of susceptibility to available agents. There will be non-susceptibility to some agents but first-line therapies are reliably active.

A global health initiative that works to improve access to and affordability of drugs, diagnostics, and other health tools for HIV/AIDS, malaria, and tuberculosis in low- and middle-income countries. It operates by shaping markets and investing in innovations.

Urinary tract infection

Uncomplicated urinary tract infection

Ventilator-associated bacterial pneumonia